Xpo is a conglomerate type stk and folks have begun to ask what if you spun off some businesses and that's what got the stock top perk up on Oct 5th. XPO Logistics +3% on asset sale report, Cowen confidence Oct. 5, 2020 9:03 AM ET|About: XPO Logistics, Inc. (XPO)| XPO Logistics (NYSE:XPO) is higher on reports that the European supply chain business is on the sales block in deal that could fetch as much as $4B to $5B. XPO was also named a top transportation pick at Cowen today, with its exposure to automation and robotics seen separating it from the pack.<--- VAN Notably, Cowen's price target of $119 reps more than 33% upside potential for shares. from--> $89.00== So this move is really $89--> $106 Quite the month. Normally my buy point would be $94.... But in this market $101...
Evoqua Water EPS beats by $0.07, beats on revenue Nov. 17, 2020 7:02 AM ET|About: Evoqua Water Technologies... (AQUA)| Evoqua Water (NYSE:AQUA): Q4 Non-GAAP EPS of $0.29 beats by $0.07; GAAP EPS of $0.26 beats by $0.07. Revenue of $383.9M (-6.9% Y/Y) beats by $10.05M. Shares +3.9% PM.
It feels like a correction is coming. We have the excitement of vaccines running into the reality of a 2nd wave slowdown, partial closing of the economy and lack of federal stimulus. If Republicans don't want to accept Joe Biden as President now then why would they want to help him help others later? It's the people left behind. Regular people. The best me and you can do is be aware that this run up is going to run smack into an air pocket. I think we have to sell the reopening plays not buy hem. It may be another year before we get this Covid vaccine. 'Sell the vaccine' - BofA's Michael Hartnett Nov. 17, 2020 7:46 AM ET|About: iShares MSCI Emerging Ma... (EEM)| "[A] topping process is underway," says Bank of America strategist Michael Hartnett. His bank's most recent fund manager survey shows soaring investor sentiment following the election and announcement of two apparently successful vaccines. Allocations to equities jumped to their highest level since January 2018, while cash plunged to its lowest level since April 2015. As the price action of the last two weeks has shown, it was small-caps, value names, banks, and emerging-market stocks that have been the favorites in this move, according to the survey. More: 91% of those surveyed see a stronger economy in 12 months, a record 73% expect a steeper yield curve, a net 24% expect value to outperform growth. Hartnett again: "We're close to 'full bull' ... Reopening rotation can continue in Q4, but we say 'sell the vaccine' in coming weeks."
I think they should be added to the S&P 100. https://www.marketvolume.com/indexe...ue chip stocks across diverse industry groups. It needs an intermodal in there anyway. UPS and FDX are different. So for now Stoney... thumbs up. Just remember its a cyclical in a way, so if the economy tanks... but for now its blue skies ahead I guess.
Trulieve Cannabis EPS misses by $0.06, beats on revenue Nov. 17, 2020 6:35 AM ET|About: Trulieve Cannabis Corp. (TCNNF)| Trulieve Cannabis (OTCQX:TCNNF): Q3 GAAP EPS of $0.15 misses by $0.06. Revenue of $136.3M (+92.8% Y/Y) beats by $4.3M. "Our third quarter was especially memorable because we introduced the long-awaited edibles product lines to our offerings and announced our acquisitions in Pennsylvania, where we see tremendous growth potential," stated Kim Rivers, Trulieve CEO.
GUMMY OF THE DAY IS IT EVOQUA! I JUST LIKE SAYING THE NAME. Or is it..... Neptune Wellness Solutions secures purchase orders worth $100M Nov. 17, 2020 5:06 AM ET|About: Neptune Wellness Solutions... (NEPT)| Neptune Wellness Solutions (NASDAQ:NEPT) soars 12% premarket after its division Neptune Health and Wellness Innovation landed an aggregate of over $100M in new delivery orders. The purchase orders come from six different clients. "We are continuing to vet and add additional products in specific areas which we've identified as having the greatest opportunity for growth and success in the health and wellness space, including in personal protective equipment," a spokesperson for the company said. Also, the company reported solid FQ2 results, with a robust top line growth of 340% Y/Y. On a sequential basis, revenue increased 155%. Year-to-date in fiscal 2021, revenues now totaled C$40M compared to C$10.9M, an increase of 267% from the same period last year. The FQ2 was transitional, and it will continue through FQ3. The increase is attributable to new health and wellness products such as thermometers and hand sanitizers, and cannabis-related products. "We remain committed to increasing shareholder value as well as confidence and these Purchase Orders are evidence that our B2B and B2C dual go-to-market strategy to serve consumers at both wholesale and retail levels, is yielding consistent, long-term revenue opportunities," added the spokesperson. The company has secured a footprint for Mood Ring of at least 515 retail stores across two Canadian provinces from regulators, with the opportunity to scale to an additional 582 retailers; this provides Mood Ring access to 80% of the Canadian market. In line with that, Neptune anticipates FQ4 revenue to accelerate at a greater speed than FQ3. Mood Ring! No. Not that again....
I don't own a cellphone. I am one of the very last of my kind on earth. Has anyone seen ericsson phones?... we ran across this name yesterday and I can't believe they are still around I lump them in with failed phones of the past... Ericsson forecasts $31T 5G consumer revenue by 2030 Nov. 17, 2020 5:34 AM ET|About: Telefonaktiebolaget LM ... (ERIC)| Ericsson's (NASDAQ:ERIC) ConsumerLab reports that 5G could drive up to $31T in cumulative consumer revenue in the ICT industry by 2030 The report estimates that communications service providers could earn $3.7T of that total. Ericsson could get a small portion of that....
Telefonaktiebolaget LM Ericsson (publ) (ERIC) 12.09+0.21 (+1.77%) At close: November 16 4:00PM EST 12.12+0.03 (0.25%) Before hours:8:06AM EST Ericsson upgraded to Buy from Hold at Societe Generale 05:15 ERIC Societe Generale analyst Aleksander Peterc upgraded Ericsson to Buy from Hold with a SEK 121 price target. Very confusing. Ericsson price target raised to SEK 125 from SEK 110 at Barclays 10/22 ERIC Barclays analyst Andrew Gardiner raised the firm's price target on Ericsson to SEK 125 from SEK 110 and keeps an Overweight rating on the shares. The question is are we getting a series B here? or somesort of offshoot of a larger priced stocl. Lets assume it's staright up then--- 123 Swedish Krona equals 14.28United States Dollar & the stock is at $12........